Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (FRA:FDY)
Germany flag Germany · Delayed Price · Currency is EUR
0.3420
+0.0020 (0.59%)
At close: Jan 30, 2026

FRA:FDY Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,1191,0561,1961,2891,2091,397
Short-Term Investments
---30--
Cash & Short-Term Investments
1,1191,0561,1961,3191,2091,397
Cash Growth
7.71%-11.67%-9.35%9.13%-13.46%142.18%
Accounts Receivable
365.09469.96620.49679.12672.49583.1
Other Receivables
2.60.070.165.141.180.91
Receivables
367.68470.03620.64684.26673.66584
Inventory
31.0447.2743.6540.5335.6336.01
Other Current Assets
18.2433.29.2425.19.779.67
Total Current Assets
1,5361,6071,8692,0691,9282,027
Property, Plant & Equipment
476.81503.53475.33351.51301.92248.77
Long-Term Investments
249.31257.49287.53306.37327.8666.71
Other Intangible Assets
64.0468.6586.3562.3288.4656.18
Long-Term Deferred Tax Assets
133.28133.28100.8785.979.2262.97
Long-Term Deferred Charges
---43.0936.1232.53
Other Long-Term Assets
6.7916.7757.1857.6219.646.97
Total Assets
2,4662,5872,8772,9762,7812,501
Accounts Payable
5.6710.678.057.438.175.27
Accrued Expenses
2.1128.6936.8634.6753.7848.73
Short-Term Debt
---101--
Current Portion of Leases
5.316.16.338.228.686.09
Current Income Taxes Payable
9.27-1.611.6310.44.6
Current Unearned Revenue
5.968.340.260.31348.87297.01
Other Current Liabilities
148.58197.16451.9520.0998.366.22
Total Current Liabilities
176.89250.95505.02673.34528.2427.93
Long-Term Leases
10.6514.4310.9515.622.5913.6
Long-Term Unearned Revenue
19.5115.852.1534.0440.850.69
Total Liabilities
207.05281.23518.12722.99591.58492.21
Common Stock
103.66103.66103.66102.9104.3104.3
Additional Paid-In Capital
1,2911,2901,2891,2251,2651,200
Retained Earnings
869.87916.9970.46934.39868.43707.28
Treasury Stock
-----40.82-
Comprehensive Income & Other
-5.81-5.55-5.86-5.2-4.05-0.77
Total Common Equity
2,2582,3052,3582,2572,1932,011
Minority Interest
0.510.711.01-4.08-3.36-2.44
Shareholders' Equity
2,2592,3052,3592,2532,1902,008
Total Liabilities & Equity
2,4662,5872,8772,9762,7812,501
Total Debt
15.9520.5317.28124.8131.2619.69
Net Cash (Debt)
1,1031,0361,1791,1941,1781,377
Net Cash Growth
7.34%-12.12%-1.33%1.43%-14.49%226.58%
Net Cash Per Share
1.341.001.141.161.131.39
Filing Date Shares Outstanding
1,0371,0371,0371,0291,0321,043
Total Common Shares Outstanding
1,0371,0371,0371,0291,0321,043
Working Capital
1,3591,3561,3641,3961,4001,599
Book Value Per Share
2.182.222.272.192.121.93
Tangible Book Value
2,1942,2362,2712,1952,1041,955
Tangible Book Value Per Share
2.122.162.192.132.041.87
Buildings
-368.53199.22198.52198.52197.33
Machinery
-504.91388.63341.74322.86292.69
Construction In Progress
-7.2229.96122.3748.91.83
Source: S&P Global Market Intelligence. Standard template. Financial Sources.